CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 183 enrolled
Drug / intervention
QUESTIONNAIRE ON SMOKING HABITSbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02570750
NCT02570750N/ACompleted

Non-interventional Study Of The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis

Pfizer·observational·Posted Oct 7, 2015·Updated Dec 20, 2018

In Brief

An observational study evaluating QUESTIONNAIRE ON SMOKING HABITS for Chronic Plaque Psoriasis. Completed, enrolled 183 participants across 30 sites.

Detailed Summary

The main purpose of this study is to assess the effect of smoking status on the success of Etanercept therapy in patients with moderate-to-severe psoriasis.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesRomania
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 7, 2015
Enrollment StartMay 7, 2015
Primary CompletionDec 5, 2016
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 10.7 years ago

Interventions

QUESTIONNAIRE ON SMOKING HABITSbehavioral

Data on smoking will include the age at which cigarette smoking began and ceased and the average amount smoked daily. Intensity (number of cigarettes smoked per day), duration of smoking (years), and time since cessation (years) will be categorized. Also, the smoking status of the patient prior psoriasis diagnosis will be assessed (smoker or non-smoker and years of smoking prior to psoriasis diagnosis). Smoking habit evaluation: baseline and changes in smoking habit at 12 and 24-weeks follow-up time points.